Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
Wenya Weng (Weng W), Tingwen Ge (Ge T), Yi Wang (Wang Y), Lulu He (He L), Tinghao Liu (Liu T), Wanning Wang (Wang W), Zongyu Zheng (Zheng Z), Lechu Yu (Yu L), Chi Zhang (Zhang C), Xuemian Lu (Lu X)
Diabetes Metab J. 2020;44(4):566-580.   Published online 2020 May 15     DOI: https://doi.org/10.4093/dmj.2019.0089
Citations to this article as recorded by Crossref logo
FGF21 and Chronic Kidney Disease
João Victor Salgado, Miguel Angelo Goes, Natalino Salgado Filho
Metabolism.2021; 118: 154738.     CrossRef
FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
Emma Henriksson, Birgitte Andersen
Frontiers in Endocrinology.2020;[Epub]     CrossRef
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
Erik J. Tillman, Tim Rolph
Frontiers in Endocrinology.2020;[Epub]     CrossRef